CA-TALKDESK
30.6.2022 11:32:07 CEST | Business Wire | Press release
Talkdesk®, Inc. , a global cloud contact center leader for customer-obsessed companies, and NetNordic Denmark , a system integrator in cloud and the only authorized Talkdesk partner in the Nordics, are collaborating to deliver a contact center solution for Nilfisk . The Danish pioneer in cleaning technology and premium cleaning products selected the Talkdesk solution – with implementation by NetNordic – because its unique artificial intelligence (AI)-powered workforce engagement features will allow Nilfisk to transform both the agent and customer experience (CX).
Danish engineer P.A. Fisker founded Nilfisk in 1906, inspired by a love of knowledge and his ambition to build a company driven by technology. In 1910, the company developed and patented the first electric vacuum cleaner in Europe, setting the foundations for a 100+ year commitment to delivering innovative cleaning solutions. Today, Nilfisk continues to advance floorcare and cleaning technology across the globe. As one of the world’s leading manufacturers of professional cleaning equipment, Nilfisk products are sold in more than 100 countries.
Talkdesk CX Cloud™ , an end-to-end customer experience solution, will provide Nilfisk with a modernized, cloud-based contact center platform that can grow with the company at scale. Talkdesk Quality Management™ will enable Nilfisk to leverage intelligent contact monitoring and reporting features for a more holistic view of customer satisfaction and agent effectiveness. AI-powered Talkdesk QM Assist™ will automate the quality management process with searchable transcripts and sentiment analysis, ultimately supporting more meaningful and effective real-time coaching opportunities for the Nilfisk team of customer care agents working across global regions. Additionally, Talkdesk for Salesforce™ will streamline operations while maintaining personalized engagement across channels.
“We aim to provide seamless experiences across every touch point for our customers,” said Ben Quirk, vice president, customer care, US & Europe at Nilfisk. “Monitoring those contact touch points to support our agents in delivering the best experience possible is an integral part of our customer commitment. The Talkdesk solution will allow Nilfisk to automate our quality management efforts. We estimate that Talkdesk AI-powered features can streamline 50% to 75% of the contact monitoring process for our managers – allowing them to assess a larger volume of conversations and provide real-time coaching for our customer care agents.”
“NetNordic has been a trusted, global unified communications advisor to Nilfisk for many years, and we have close knowledge of Nilfisk operations through this valued collaboration,” said Jan Brandi, sales specialist UC and contact center at NetNordic. “We believe the Talkdesk-powered contact center will streamline operations for Nilfisk and provide their customers with highly personalized engagements. We are pleased to support Nilfisk in implementing and maintaining their new global cloud solution.”
“No matter the product category, there is a universal truth for brands – the quality of the product is important, but the ability to answer customer inquiries and deliver a delightful experience is everything . Brands that seek to evaluate and learn from their customer interactions will cultivate CX strategies that ensure long-lasting relationships and brand loyalty,” said Tiago Paiva, chief executive officer, Talkdesk. “With the Talkdesk solution, Nilfisk can make every customer conversation matter. We’re proud to partner with NetNordic and Nilfisk to create customer experiences that delight.”
Additional Resources
- See Talkdesk recognized as a Leader in the Gartner 2021 Magic Quadrant for Contact Center as a Service
- Hear from customers about why they selected Talkdesk CX Cloud and the difference it has made in their contact centers
Social Networks
- Web: https://www.talkdesk.com/customer-community/
- Blog: https://www.talkdesk.com/blog/
- Twitter: https://twitter.com/Talkdesk
- LinkedIn: https://www.linkedin.com/company/talkdesk/
- Facebook: https://www.facebook.com/Talkdesk/
- Instagram: https://www.instagram.com/Talkdesk/
About Talkdesk
Talkdesk® is a global cloud contact center leader for customer-obsessed companies. Our automation-first customer experience solutions optimize our customers’ most critical customer service processes. Our speed of innovation, vertical expertise, and global footprint reflect our commitment to ensuring that businesses can deliver better experiences across any industry and through any channel, resulting in higher customer satisfaction and accelerated business outcomes.
Talkdesk is a registered trademark of Talkdesk, Inc. All product and company names are trademarks™ or registered ® trademarks of their respective holders. Use of them does not imply any affiliation or endorsement by them.
About NetNordic
NetNordic Group is a Nordic system integrator specializing in secure infrastructure, network, collaboration, and multi-cloud and application enablement. NetNordic delivers customer-specific solutions and services. We always strive to be our customers' "Best Companion", we want to help our customers with their digital enabling through design, delivery and management of the next generation of services and solutions.
About the Talkdesk partner ecosystem:
The Talkdesk global ecosystem represents a diverse network of best-in-class resellers, strategic alliance partners, cloud distributors, and technology vendors focused on providing a better way for organizations to create more meaningful and memorable moments with their customers. These partners support Talkdesk in helping customers across industries and around the world deliver customer experiences that build trust and loyalty.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220630005097/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
